Filing Details

Accession Number:
0001225208-13-025402
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-12-13 18:45:16
Reporting Period:
2013-12-11
Filing Date:
2013-12-13
Accepted Time:
2013-12-13 18:45:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
9892 Bard C R Inc BCR Surgical & Medical Instruments & Apparatus (3841) 221454160
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1403373 A John Deford C/O C. R. Bard, Inc.
730 Central Avenue
Murray Hill NJ 07974
Sr. Vp Sci Tech And Clin Afrs No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-12-11 3,543 $0.00 36,335 No 4 A Direct
Common Stock Disposition 2013-12-12 2,792 $133.98 33,543 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (Right to Buy) Acquisiton 2013-12-11 16,643 $0.00 16,643 $136.37
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
16,643 2023-12-11 No 4 A Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 13 Indirect 401(k) Plan
Footnotes
  1. Reflects restricted stock units, each of which represents a contingent right to receive one share of common stock. These restricted stock units, granted under the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated), vest in three installments - 50% upon certification of achievement of certain performance criteria measured over a two-year performance period, and 25% on each of the first and second anniversaries of the certification that the performance criteria has been achieved.
  2. Sales are pursuant to a previously disclosed 10b5-1 plan.
  3. Represents the weighted average sales price for price increments ranging from $133.54 to $134.37. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
  4. Options granted under the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
  5. Options vest in four equal annual installments beginning on December 11, 2014.